Oral Biologics & Biosimilars Market Global Report 2020-30

7616
Pages: 200
April 2020
Total Views:1458
Region : Global
The Business Research Company
Market Research Report

Bundle Purchase

Select a License

Single User License

USD 4000

Hard Copy License

USD 4000

Site License

USD 6000

CD-Rom

USD 4000

Corporate User License

USD 8000

Details

The oral biologics and biosimilar market consist of sales of oral biologics and biosimilar products and related services used to treat chronic diseases such as diabetes, arthritis, cancer. Biologics are drugs made from living cells using highly complex technology while biosimilars are created to function similarly to biologics but are not identical to biologics. Biosimilars offer active properties as any licensed biologic drug. The oral biologics and biosimilar market comprise of biologics and biosimilar drugs taken orally for the targeted treatment of Alzheimer's, multiple sclerosis, HIV/AIDS and other serious conditions.

The global oral biologics & biosimilars market was worth USD 1.15 billion in 2019. It is expected to grow at a compound annual growth rate (CAGR) of 34.31% and reach USD 3.74 billion by 2023.

The oral biologics and biosimilar market covered inthis report is segmented by therapy into lymphocyte modulators, interleukin inhibitors, tumor necrosis factor-alpha inhibitors. It is also segmetned by disease into asthma, crohn's disease, carcinoma, arthritis, diabetes, multiple myeloma, enterocolitis, multiple sclerosis, sarcoma, psoriasis and others.

The rising prevalence of chronic diseases such as arthritis, asthma, cancer is expected to be a major driver of the oral biologics and biosimilar market. Long working hours, limited physical activity, unhealthy eating and drinking habits contribute to the prevalence of chronic diseases and biologics are increasingly used to treat these chronic diseases. Biologics activate the immune system response against cancer cells thus helping the immune system to eliminate the cancer cells from the body. According to a United Nations article, by 2030 the proportion of global deaths due to chronic diseases is expected to increase to 70% of total deaths. The global burden of chronic disease is expected to reach about 60%. Therefore, the rise in the prevalence of chronic diseases is projected to propel the demand for biologics and biosimilars, thus driving the biologics and biosimilar market.

Stringent regulations imposed on approval of biosimilar is anticipated to hinder the growth of oral biologics and biosimilar market in the forecast period. The governments of different regions impose different rules regarding the production and use of biologics and biosimilars. Further, issues such as patent infringement or agreement issues restrict the manufacturers of biologics and biosimilars from commercializing the government-approved biosimilars. The US Food and Drug Administration requires a double regulatory approval for biosimilars, restricting the use of biosimilars as an interchangeable drug to biologics whereas, in Europe, the European Medicines Agency (EMA) approves biosimilars as interchangeable products for biologics. In February 2019, out of the total 17 approved biosimilars only 7 biosimilars including 4 originating biologics could enter the US commercial market. The robust government policies for approval of these drugs impact the manufacturers in oral biologics and biosimilar market.

The latest trend in the oral biologics and biosimilar market is the creation of new insulin biosimilars. The key players operating in the oral biologics and biosimilar market are investing in creating a biosimilar copy of insulin. This is also promoting competition among various biosimilar manufacturers. Following the trend, Mylan, a USA based pharmaceuticals company, in partnership with Biocon launched biosimilar insulin glargine named Semglee, in 2019 in Australia. Biocon is an Indian based biopharmaceutical company. In 2019, Oramed Pharmaceuticals, a Jerusalem based pharmaceutical company developed an oral insulin drug named ORMD-0801 to treat type 2 diabetes. Thus, companies in the oral biologics and biosimilar market are investing in the trend of developing biosimilar of insulin to gain profit.

Major players in the market are Novartis, Rani Therapeutics, Eli Lilly and Co., AstraZeneca plc, Novo Nordisk A/S, Biocon Limited, Oramed Pharmaceuticals, BiosanaPharma, Entera Bio Ltd. and Allergan plc.

Scope

1. Executive Summary

2. Oral Biologics & Biosimilars Market Market Characteristics

3. Oral Biologics & Biosimilars Market Market Size And Growth

3.1. Global Oral Biologics & Biosimilars Market Historic Market, 2015-2019, USD Billion

3.1.1. Drivers Of The Market

3.1.2. Restraints On The Market

3.2. Global Oral Biologics & Biosimilars Market Forecast Market, 2019-2023F, 2025F, 2030F, USD Billion

3.2.1. Drivers Of The Market

3.2.2. Restraints On the Market

4. Oral Biologics & Biosimilars Market Market Segmentation

4.1. Global Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Lymphocyte Modulators

Interleukin Inhibitors

Tumor Necrosis Factor-Alpha Inhibitors

4.2. Global Oral Biologics & Biosimilars Market Market, Segmentation By Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Asthma

Crohn'S Disease

Carcinoma

Arthritis

Diabetes

Multiple Myeloma

Enterocolitis

Multiple Sclerosis

Sarcoma

Psoriasis and Others

5. Oral Biologics & Biosimilars Market Market Regional And Country Analysis

5.1. Global Oral Biologics & Biosimilars Market Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

5.2. Global Oral Biologics & Biosimilars Market Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

6. Asia-Pacific Oral Biologics & Biosimilars Market Market

6.1. Asia-Pacific Oral Biologics & Biosimilars Market Market Overview

6.2. Asia-Pacific Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

7. China Oral Biologics & Biosimilars Market Market

7.1. China Oral Biologics & Biosimilars Market Market Overview

7.2. China Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,USD Billion

8. India Oral Biologics & Biosimilars Market Market

8.1. India Oral Biologics & Biosimilars Market Market Overview

8.2. India Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

9. Japan Oral Biologics & Biosimilars Market Market

9.1. Japan Oral Biologics & Biosimilars Market Market Overview

9.2. Japan Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

10. Australia Oral Biologics & Biosimilars Market Market

10.1. Australia Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

11. Indonesia Oral Biologics & Biosimilars Market Market

11.1. Indonesia Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

12. South Korea Oral Biologics & Biosimilars Market Market

12.1. South Korea Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

13. Western Europe Oral Biologics & Biosimilars Market Market

13.1. Western Europe Oral Biologics & Biosimilars Market Market Overview

13.2. Western Europe Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

14. UK Oral Biologics & Biosimilars Market Market

14.1. UK Oral Biologics & Biosimilars Market Market Overview

14.2. UK Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

15. Germany Oral Biologics & Biosimilars Market Market

15.1. Germany Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

16. France Oral Biologics & Biosimilars Market Market

16.3. France Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

17. Eastern Europe Oral Biologics & Biosimilars Market Market

17.1. Eastern Europe Oral Biologics & Biosimilars Market Market Overview

17.2. Eastern Europe Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

18. Russia Oral Biologics & Biosimilars Market Market

18.1. Russia Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

19. North America Oral Biologics & Biosimilars Market Market

19.1. North America Oral Biologics & Biosimilars Market Market Overview

19.2. North America Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

20. USA Oral Biologics & Biosimilars Market Market

20.1. USA Oral Biologics & Biosimilars Market Market Overview

20.2. USA Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

21. South America Oral Biologics & Biosimilars Market Market

21.1. South America Oral Biologics & Biosimilars Market Market Overview

21.2. South America Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

22. Brazil Oral Biologics & Biosimilars Market Market

22.1. Brazil Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

23. Middle East Oral Biologics & Biosimilars Market Market

23.1. Middle East Oral Biologics & Biosimilars Market Market Overview

23.2. Middle East Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

24. Africa Oral Biologics & Biosimilars Market Market

24.1. Africa Oral Biologics & Biosimilars Market Market Overview

24.2. Africa Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

25. Oral Biologics & Biosimilars Market Market Competitive Landscape And Company Profiles

25.1. Oral Biologics & Biosimilars Market Market Competitive Landscape

25.2. Oral Biologics & Biosimilars Market Market Company Profiles

25.2.1. Novartis

25.2.1.1. Overview

25.2.1.2. Products and Services

25.2.1.3. Strategy

25.2.1.4. Financial Performance

25.2.2. Rani Therapeutics

25.2.2.1. Overview

25.2.2.2. Products and Services

25.2.2.3. Strategy

25.2.2.4. Financial Performance

25.2.3. Eli Lilly and Co.

25.2.3.1. Overview

25.2.3.2. Products and Services

25.2.3.3. Strategy

25.2.3.4. Financial Performance

25.2.4. AstraZeneca plc

25.2.4.1. Overview

25.2.4.2. Products and Services

25.2.4.3. Strategy

25.2.4.4. Financial Performance

25.2.5. Novo Nordisk A/S

25.2.5.1. Overview

25.2.5.2. Products and Services

25.2.5.3. Strategy

25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Oral Biologics & Biosimilars Market Market

27. Oral Biologics & Biosimilars Market Market Trends And Strategies

28. Oral Biologics & Biosimilars Market Market Future Outlook and Potential Analysis

29. Appendix

29.1. Abbreviations

29.2. Currencies

29.3. Research Inquiries

29.4. The Business Research Company

29.5. Copyright And Disclaimer

List Of Figure

Figure 1: Global Historic Market Growth, 2015-2019, USD Billion

Figure 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 3: Global Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 4: Global Oral Biologics & Biosimilars Market Market, Segmentation By Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 5: Global Oral Biologics & Biosimilars Market Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 6: Global Oral Biologics & Biosimilars Market Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 7: Asia-Pacific, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 8: China, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 9: India, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 10: Japan, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 11: Australia, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 12: Indonesia, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 13: South Korea, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 14: Western Europe, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 15: UK, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 16: Germany, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 17: France, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 18: Eastern Europe, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 19: Russia, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 20: North America, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 21: USA, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 22: South America, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 23: Brazil, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 24: Middle East, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 25: Africa, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 26: Novartis Financial Performance

Figure 27: Rani Therapeutics Financial Performance

Figure 28: Eli Lilly and Co. Financial Performance

Figure 29: AstraZeneca plc Financial Performance

Figure 30: Novo Nordisk A/S Financial Performance

List Of Table

Table 1: Global Historic Market Growth, 2015-2019, USD Billion

Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 3: Global Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 4: Global Oral Biologics & Biosimilars Market Market, Segmentation By Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 5: Global Oral Biologics & Biosimilars Market Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 6: Global Oral Biologics & Biosimilars Market Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 7: Asia-Pacific, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 8: China, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 9: India, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 10: Japan, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 11: Australia, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 12: Indonesia, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 13: South Korea, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 14: Western Europe, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 15: UK, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 16: Germany, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 17: France, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 18: Eastern Europe, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 19: Russia, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 20: North America, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 21: USA, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 22: South America, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 23: Brazil, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 24: Middle East, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 25: Africa, Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 26: Novartis Financial Performance

Table 27: Rani Therapeutics Financial Performance

Table 28: Eli Lilly and Co. Financial Performance

Table 29: AstraZeneca plc Financial Performance

Table 30: Novo Nordisk A/S Financial Performance

Licence Rights

Single User License (for access by one person)
Site License (for access of one office location of a company)
Corporate License (allow access by all staff of the company)

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

1) By Therapy: Lymphocyte Modulators; Interleukin Inhibitors; Tumor Necrosis Factor-Alpha Inhibitors; 2) By Disease: Asthma; Crohn'S Disease; Carcinoma; Arthritis; Diabetes; Multiple Myeloma; Enterocolitis; Multiple Sclerosis; Sarcoma; Psoriasis and Others

Companies

Novartis; Rani Therapeutics; Eli Lilly and Co.; AstraZeneca plc; Novo Nordisk A/S; Biocon Limited; Oramed Pharmaceuticals; BiosanaPharma; Entera Bio Ltd.; Allergan plc; Emisphere Technologies; Enteris BioPharma; Chiasma; Allena Pharmaceuticals; Gelgen; Ganlee; 3sbio; Innovent; Retractable Technologies, Inc.; Changchun High Tech; Dong Bao; CP Guojian; GlaxoSmithKline Plc.; Concord Biotech; Aurobindo Pharma Ltd.; H. Lundbeck A/S; Sanofi-Aventis; Roche

Company Profile

Company Profile Title

Single User Licence

USD 200

Corporate User Licence

USD 500